Clinical Lab 2.0:
How the Laboratory Can Support Value Based Care, Optimize Patient Outcomes, and Reduce Total Costs of Care?<\/p>
<\/p>
Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in\u00a0Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute\u00a0which performs clinical device trials, offers central lab services, and maintains asample biorepository.<\/p>\n
He is also the laboratory director of TriCore\u2019s core laboratory, is the medical<\/p>\n
director of immunology and point-of-care testing, and a clinical professor of<\/p>\n
pathology at the University of New Mexico. He is the immediate past president of the\u00a0American Association for Clinical Chemistry.<\/p>\n
Dr. Grenache earned his PhD in biomedical sciences from WPI in Worcester,<\/p>\n
Massachusetts, and completed postdoctoral training in clinical chemistry at<\/p>\n
Washington University School of Medicine in St. Louis, Missouri. He is a diplomate of\u00a0the American Board of Clinical Chemistry and a Fellow in the AACC Academy. His\u00a0research interests are centered on leveraging longitudinal laboratory data to gain\u00a0insights into population health and the diagnostic tests used to manage the pregnant\u00a0patient.<\/p>\n
\u00a0<\/p>